• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD

ADALTA LIMITED

0.00% ! 0.3¢
Market Cap $2.516M  !

AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company... AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 13/06/25 0 133
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  133 
1AD 13/06/25 0 103
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  103 
1AD 13/06/25 0 97
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  97 
1AD 13/06/25 0 156
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  156 
1AD 11/06/25 0 225
11/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  225 
1AD 05/06/25 0 258
05/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  258 
1AD 04/06/25 1 523
04/06/25 Last post  Grana22 Comments Created with Sketch.  1  Views Created with Sketch.  523 
1AD 04/06/25 0 173
04/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  173 

See All Discussions arrow Created with Sketch.

Timeline

Change in Director Interest Notice (IR & DF)
13 Jun 10:27
 
Application for quotation of securities - 1AD
13 Jun 09:27
 
Application for quotation of securities - 1AD
13 Jun 09:27
 
Renounceable Rights Issue shortfall placed
13 Jun 09:19
 
Change in Director Interest Notice (TO, PM, IR & DF)
11 Jun 18:44
 
Change in substantial holding
05 Jun 15:56
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $2.516M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.5K 600K

Buyers (Bids)

No. Vol. Price($)
31 24234107 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 5352937 11
View Market Depth
Last trade - 15.25pm 13/06/2025 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.